My survival is based on research. With limited NIH funding, I fear that my life, and the lives of others, will be left ...

Treatment with the T-cell immunotherapy Orca-T improved survival free of moderate-to-severe chronic graft-versus-host disease ...

Our blood consists of many cell types that develop through different stages from a precursor type -- the blood stem cell. An international research team has now investigated the developmental pathways ...

Previously reported Phase 1/2 data on WU-CART-007 demonstrated clinically manageable safety and evidence of anti-leukemic activity with an ...

But some cancer cells can evade detection by CAR-T cells, leading to treatment failure and relapse. Using human T cells and ...

The rate of cGVHD-free survival was 78% at 1 year in patients who received Orca-T compared with 38% among patients who ...

Researchers at the University of Houston, in collaboration with Baylor College of Medicine, are developing new devices for ...

Researchers uncover how leukemia drains T cells' energy, paving the way for stronger cancer immunotherapy and enhancing CAR T ...

Learn the essential early warning signs of leukemia that are often dismissed as everyday ailments but could be indicators of ...

Scientists have supercharged CAR-T therapy, making it more powerful against elusive cancer cells that usually escape ...

In a late-stage trial of patients with multiple types of blood cancer, Orca Bio’s allogeneic T-cell immunotherapy doubled the ...